Interested in specific Information?

Filter what you see here

Patients eligible for transplant

Quick poll

Long-term results from the HOVON-50 trial on the use of thalidomide for…

Long-term results from the HOVON-50 trial on the use of thalidomide for newly diagnosed multiple myeloma

Closes Nov 8, 2018

Relapsed/refractory patients

Quick poll

FDA approves elotuzumab in combination with pomalidomide and dexamethasone…

Closes Nov 8, 2018 , Expert Opinion

General MM

Quick poll

ESH MM 2018 | Assessment of response in multiple myeloma

Closes Nov 1, 2018

Patients eligible for transplant,   Patients non-eligible for transplant

Quick poll

ESH MM 2018 | Continuous or fixed-duration therapy in multiple myeloma?

ESH MM 2018 | Continuous or fixed-duration therapy in multiple myeloma?

Closes Oct 30, 2018

Patients eligible for transplant,   Patients non-eligible for transplant

Quick poll

ESH MM 2018 | How to treat newly diagnosed multiple myeloma

Closes Oct 29, 2018

Relapsed/refractory patients

Quick poll

FDA grants Orphan Drug Designation to STRO-001 for the treatment of…

Closes Oct 17, 2018

General MM

Quick poll

Supportive care: managing infection in myeloma | An interview with Heinz…

Supportive care: managing infection in myeloma | An interview with Heinz Ludwig

Closes Oct 12, 2018

General MM

Quick poll

Robert Hills | ESH MM 2018 | How to judge the value of a clinical trial

Closes Oct 9, 2018

Relapsed/refractory patients

Quick poll

Selinexor granted FDA priority review

Closes Oct 9, 2018

General MM

Quick poll

Kenneth Anderson | ESH MM 2018 | Future combinations for the treatment of…

Kenneth Anderson | ESH MM 2018 | Future combinations for the treatment of MM

Closes Oct 8, 2018

General MM

Quick poll

Herve Avet-Loiseau | ESH MM 2018 | Genetics and risk assessment

Closes Oct 8, 2018

General MM

Quick poll

Shaji Kumar | ESH MM 2018 | New end-points and new design for clinical…

Closes Oct 8, 2018

General MM

Quick poll

Saad Usmani | ESH MM 2018 | Progress in MM with monoclonal antibodies

Saad Usmani | ESH MM 2018 | Progress in MM with monoclonal antibodies

Closes Oct 7, 2018

General MM

Quick poll

Jesus Berdeja | ESH MM 2018 | Adoptive cell therapy

Closes Oct 7, 2018

General MM

Quick poll

 David Avignan | ESH MM 2018 | Vaccines in myeloma

Closes Oct 7, 2018
A global online educational platform sharing the latest research and emerging treatment information in multiple myeloma

Latest Medical Information

Latest Congress Coverage

Latest Biology

Relapsed/refractory patients

Evaluation of cell-free DNA as a biomarker in RRMM

Sep 11, 2018

Latest Drug Updates

Relapsed/refractory patients

FDA approves elotuzumab in combination with pomalidomide and dexamethasone for…

Nov 8, 2018 , Expert Opinion
Relapsed/refractory patients

Selinexor granted FDA priority review

Oct 9, 2018

Recently updated Licenses

Where we are next

60th ASH Annual Meeting & Exposition

December 1–4, 2018 | San Diego, CA

The meeting prides itself on bringing together professionals worldwide to highlight 'state-of-the-art clinical practice and the latest findings in hematology research'. The program covers all hematological indications, including multiple myeloma. Stay tuned to follow our first-hand ASH coverage.

#ASH18 #mmsm 

Event Website

Map Data
Map data ©2018 Google
Map DataMap data ©2018 Google
Map data ©2018 Google

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology